We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Adverse Reactions to Antibiotics Cause Thousands of ER Visits

By HospiMedica International staff writers
Posted on 03 Sep 2008
Adverse events from antibiotics cause an estimated 142,000 emergency room (ER) visits per year in the United States alone, according to a new study.

Researchers from the U.S. More...
Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) examined data from the U.S. National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project--a sample of 63 hospitals in the United States and its territories--to estimate and compare the numbers and rates of adverse events from systemic antibiotics by class, drug, and event type. Based on 6,614 cases, the researchers estimated that 142,505 visits annually were made to ERs for drug-related adverse events attributable to systemic antibiotics.

The researchers found that 50% of the ER visits were for reactions to penicillin derivatives, and the other 50% were from reactions to other antibiotics used to treat a wide variety of bacterial infections. Compared with all other antibiotic classes, sulfonamides were associated with a significantly higher rate of moderate-to-severe allergic reactions, and sulfonamides and fluoroquinolones were associated with a significantly higher rate of neurologic or psychiatric disturbances. Almost 80% of all antibiotic adverse events in the study were allergic reactions, ranging from rash to anaphylaxis, and the remaining 20% were caused by medication errors and overdoses. The researchers found that only 6% of the patients who had adverse events required hospitalization. Children less than one-year-old were found to have the highest rate of adverse drug events. The study was published in the September 15, 2008, issue of the journal Clinical Infectious Diseases.

"For conditions in which antibiotics have questionable benefit, such as many mild upper respiratory tract infections, weighing the benefits of antibiotics with the risks of a serious adverse event will be especially important,” said study author Daniel Budnitz, M.D., of the U.S. National Center for Detection, Preparedness, and Control of Infectious Diseases at the CDC. "Because antibiotics are frequently used, both appropriately and inappropriately, if doctors would reduce the number of antibiotics they prescribe to their patients by even a small percentage, we could significantly reduce the number of emergency visits for antibiotic adverse events. Physicians need to communicate to their patients that antibiotics are not harmless.”

Related Links:
Centers for Disease Control and Prevention

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.